Bausch Health Companies Inc. Capital Leases, Future Minimum Payments Due in Two Years
Bausch Health Companies Inc. (BHC) had Capital Leases, Future Minimum Payments Due in Two Years of $1.00 million as of 2017-12-31, per its 8-K filed 2018-08-10.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2018-08-10
- 2017-12-31: Capital Leases, Future Minimum Payments Due in Two Years $1.00M.
- 2016-12-31: Capital Leases, Future Minimum Payments Due in Two Years $4.00M.
- 2015-12-31: Capital Leases, Future Minimum Payments Due in Two Years $4.20M.
| Period end | Capital Leases, Future Minimum Payments Due in Two Years |
|---|---|
| 2017-12-31 | $1.00M 8-K · filed 2018-08-10 |
| 2016-12-31 | $4.00M 10-K · filed 2017-03-01 |
| 2015-12-31 | $4.20M 10-K · filed 2016-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |